Cholinesterase inhibitors (ChEIs) such as donepezil have the effect of delaying progression of Alzheimer’s disease (AD), but their effect on life expectancy is unclear. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.